Z Adam
Overview
Explore the profile of Z Adam including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
220
Citations
853
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Adam Z, cermak A, Adamova Z, rehak Z, Koukalova R, Pour L
Rozhl Chir
. 2022 Aug;
101(6):265-272.
PMID: 35973821
Idiopathic retroperitoneal fibrosis (IRF) is a rare condition characterized by the development of a peri-aortic and peri-iliac tissue showing chronic inflammatory infiltrates and pronounced fibrosis. Ureteral entrapment with consequent obstructive...
12.
Brychtova M, Vlachova M, Gregorova J, Krejci M, Adam Z, Sevcikova S
Klin Onkol
. 2021 Dec;
34(6):434-439.
PMID: 34911328
Erdheim-Chester disease is a rare inflammatory myeloid clonal disease which is classified into histiocytoses. It is characterized by excessive production and accumulation of foamy histiocytes and Touton giant cells in...
13.
Adam Z, Klimes J, Boleloucky Z, Adamova Z
Klin Onkol
. 2021 Dec;
34(4):264-272.
PMID: 34905927
Background: Improvements in cancer dia-gnosis and treatment explain a substantial increase in the number of patients chronically affected by or recovering from cancer. This is a fragile population, physically, psychologically...
14.
Koukalova R, Selingerova I, rehak Z, Adam Z, Szturz P
Klin Onkol
. 2021 Apr;
34(2):120-127.
PMID: 33906360
Background: Castleman disease (CD) is a rare lymphoproliferative disorder including unicentric and multicentric forms which can further be divided into four histopathologic variants (hyaline vascular, plasma cell, mixed, and plasmablastic)....
15.
Adam Z, Adamova Z, rehak Z, Koukalova R
Klin Onkol
. 2021 Apr;
34(2):92-102.
PMID: 33906357
Background: IgG4-related disease (IgG4-RD) is a non-malignant, chronic, immune-related disease. It was first recognized as a distinct disease in 2012 and the first classification criteria were published in 2020. This...
16.
Sandecka V, Adam Z, Krejci M, Stork M, rehak Z, Koukalova R, et al.
Neoplasma
. 2020 Jun;
67(4):939-945.
PMID: 32567936
Monoclonal gammopathy of undetermined significance (MGUS) is a known precursor of more serious cancers, such as multiple myeloma (MM), Waldenström macroglobulinemia (MW) and other lymphoproliferative disorders. Using 18F-FDG PET/CT, we...
17.
Stork M, Sandecka V, Boichuk I, Adam Z, Krejci M, Brozova L, et al.
Klin Onkol
. 2019 Dec;
32(6):445-452.
PMID: 31842563
Background: Thalidomide-and bortezomib-containing regimens are widely used for transplant-ineligible newly diagnosed multiple myeloma patients. The aim of this study was to analyse the efficiency of thalidomide-or bortezomib-based regimens in long-term...
18.
Adamova Z, Adam Z
Rozhl Chir
. 2019 Aug;
98(8):312-314.
PMID: 31462052
Surgical wound complications remain a major cause of morbidity; although usually not life threatening, they reduce the quality of life. They are also associated with excessive health care costs. Wound...
19.
Adamova Z, Adam Z
Rozhl Chir
. 2019 Aug;
98(8):308-311.
PMID: 31462051
The following review is dedicated to the impact of psychological factors on the genesis and development of malignant diseases. People suffering from stress, anxiety and depression have a higher risk...
20.
Zarska M, Vrabel D, Bezdekova R, Stork M, Jarosova M, Adam Z, et al.
Klin Onkol
. 2019 Feb;
32(1):40-46.
PMID: 30764628
Background: Plasma cell leukemia (PCL) is a rare dis-ease and possibly the most aggressive form of monoclonal gammopathy. It is classified into two forms -  primary PCL that occurs without...